🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

38,23 USD

Máx. histórico

41,81

56 días

Caída desde máximo

-8,56%

Rango 52 semanas

19,62 – 42,50

Variación hoy

+6,08%

Cierre anterior

36,04

Rango de hoy

35,71 – 38,52

Volumen hoy

10.911.067

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,51%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 2 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/09/2026 38,00 38,47 36,78 36,82 -3,66% 4,45% 9.272.900
22/09/2026 38,73 39,17 38,11 38,22 -1,97% 2,74% 6.752.500
21/09/2026 39,02 39,90 38,72 38,99 -1,96% 3,02% 5.620.100
18/09/2026 40,11 40,71 39,72 39,77 -0,53% 2,48% 32.196.300
17/09/2026 40,45 40,97 39,50 39,98 +1,04% 3,63% 7.604.000
16/09/2026 39,77 40,45 39,17 39,57 +0,18% 3,22% 6.181.200
15/09/2026 41,14 41,14 39,22 39,50 -3,71% 4,68% 8.104.600
14/09/2026 40,64 41,60 40,44 41,02 +0,49% 2,85% 7.592.500
11/09/2026 41,22 41,83 40,51 40,82 -0,29% 3,20% 5.963.900
10/09/2026 41,27 41,41 40,22 40,94 -2,08% 2,88% 6.534.000
09/09/2026 41,39 42,28 41,08 41,81 +0,80% 2,88% 11.147.100
08/09/2026 39,98 42,50 38,41 41,48 +18,75% 10,23% 24.662.900
04/09/2026 34,20 35,15 33,88 34,93 +1,51% 3,70% 5.237.900
03/09/2026 34,35 34,43 33,67 34,41 +0,67% 2,21% 6.859.200
02/09/2026 34,64 35,04 33,43 34,18 -0,98% 4,64% 6.196.100
01/09/2026 34,64 34,95 34,26 34,52 -0,35% 1,99% 6.905.900
31/08/2026 34,83 35,34 34,02 34,64 -0,20% 3,80% 39.466.600
28/08/2026 37,01 37,13 34,69 34,71 -7,64% 6,61% 8.765.000
27/08/2026 36,85 37,81 36,50 37,58 +2,26% 3,56% 4.920.800
26/08/2026 36,93 36,93 36,32 36,75 +0,77% 1,65% 5.260.300
25/08/2026 36,82 37,29 36,31 36,47 +0,30% 2,66% 4.481.400
24/08/2026 36,22 36,57 35,71 36,36 +0,17% 2,39% 5.117.100
21/08/2026 37,03 37,18 36,23 36,30 -1,47% 2,58% 6.185.500
20/08/2026 36,91 37,55 36,68 36,84 -1,50% 2,36% 3.127.800
19/08/2026 37,83 37,97 36,75 37,40 +0,08% 3,22% 5.814.700
18/08/2026 35,91 37,46 35,86 37,37 +3,12% 4,46% 6.411.100
17/08/2026 36,22 37,19 35,65 36,24 +0,11% 4,25% 7.729.900
14/08/2026 36,14 36,49 35,87 36,20 -0,22% 1,72% 4.527.200
13/08/2026 36,70 36,70 35,78 36,28 +0,33% 2,51% 6.028.100
12/08/2026 35,22 36,50 35,22 36,16 +2,58% 3,63% 4.993.000